NeuroMetrix Net Income vs Enterprise Value Analysis
NURO Stock | USD 3.65 0.08 2.24% |
NeuroMetrix financial indicator trend analysis is infinitely more than just investigating NeuroMetrix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroMetrix is a good investment. Please check the relationship between NeuroMetrix Net Income and its Enterprise Value accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
Net Income vs Enterprise Value
Net Income vs Enterprise Value Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroMetrix Net Income account and Enterprise Value. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between NeuroMetrix's Net Income and Enterprise Value is -0.26. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of NeuroMetrix, assuming nothing else is changed. The correlation between historical values of NeuroMetrix's Net Income and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of NeuroMetrix are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Net Income i.e., NeuroMetrix's Net Income and Enterprise Value go up and down completely randomly.
Correlation Coefficient | -0.26 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in NeuroMetrix financial statement analysis. It represents the amount of money remaining after all of NeuroMetrix operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Enterprise Value
Enterprise Value (or EV) is usually referred to as NeuroMetrix theoretical takeover price. In the event of an acquisition, an acquirer would have to take on NeuroMetrix debt, but would also pocket its cash. Enterprise Value is more accurate representation of NeuroMetrix value than its market capitalization because it takes into account all of NeuroMetrix existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Most indicators from NeuroMetrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroMetrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.As of the 19th of April 2024, Selling General Administrative is likely to drop to about 4.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 2.5 M
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.9M | 5.8M | 3.9M | 3.8M | Total Revenue | 8.3M | 8.3M | 5.9M | 5.6M |
NeuroMetrix fundamental ratios Correlations
Click cells to compare fundamentals
NeuroMetrix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NeuroMetrix fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 121.0K | 376.8K | 638.9K | 891.3K | 1.0M | 1.1M | |
Total Assets | 6.9M | 8.0M | 24.9M | 24.7M | 21.4M | 17.5M | |
Other Current Liab | 2.1M | 1.5M | 853.2K | 589.9K | 1.2M | 1.9M | |
Total Current Liabilities | 3.4M | 2.3M | 1.4M | 1.1M | 1.2M | 1.2M | |
Total Stockholder Equity | 2.5M | 5.2M | 23.2M | 23.4M | 20.1M | 14.4M | |
Property Plant And Equipment Net | 1.4M | 876.2K | 673.9K | 536.2K | 543.6K | 599.7K | |
Net Debt | (2.2M) | (4.8M) | (22.3M) | (3.9M) | (1.5M) | (1.6M) | |
Retained Earnings | (194.8M) | (196.9M) | (199.2M) | (203.6M) | (210.1M) | (220.6M) | |
Accounts Payable | 725.7K | 142.3K | 284.0K | 368.1K | 215.5K | 204.7K | |
Cash | 3.1M | 5.2M | 22.6M | 4.3M | 1.7M | 1.6M | |
Non Current Assets Total | 1.5M | 904.7K | 700.3K | 562.6K | 570.0K | 541.5K | |
Non Currrent Assets Other | 74.9K | 29.7K | 28.5K | 26.4K | 30.4K | 31.9K | |
Other Assets | 30.3K | 29.7K | 721.2K | 700.3K | 630.3K | 600.4K | |
Cash And Short Term Investments | 3.1M | 5.2M | 22.6M | 21.2M | 18.0M | 12.0M | |
Net Receivables | 488.0K | 334.3K | 310.8K | 646.8K | 518.8K | 492.9K | |
Common Stock Total Equity | 271.0 | 738.0 | 140.0 | 379.0 | 341.1 | 669.34 | |
Liabilities And Stockholders Equity | 6.9M | 8.0M | 24.9M | 24.7M | 21.4M | 17.5M | |
Non Current Liabilities Total | 916.7K | 461.4K | 306.7K | 207.5K | 92.5K | 87.9K | |
Inventory | 1.2M | 1.1M | 706.6K | 1.6M | 1.6M | 1.6M | |
Other Current Assets | 2.3M | 1.9M | 1.6M | 2.9M | 779.0K | 740.1K | |
Other Stockholder Equity | 197.3M | 202.1M | 222.4M | 226.9M | 230.0M | 241.5M | |
Total Liab | 4.4M | 2.7M | 1.7M | 1.3M | 1.3M | 1.3M | |
Property Plant And Equipment Gross | 1.4M | 183.5K | 2.0M | 1.2M | 1.3M | 926.1K | |
Total Current Assets | 5.4M | 7.1M | 24.2M | 24.1M | 20.9M | 15.7M | |
Accumulated Other Comprehensive Income | (1.1M) | (1.2M) | (1.2M) | 240.2K | 216.2K | 227.0K | |
Common Stock | 140.0 | 379.0 | 668.0 | 778.0 | 152.0 | 144.4 | |
Property Plant Equipment | 2.4M | 273.4K | 183.5K | 673.9K | 606.5K | 621.0K | |
Retained Earnings Total Equity | (191.3M) | (191.0M) | (194.8M) | (196.9M) | (177.2M) | (186.1M) | |
Net Tangible Assets | 6.1M | 2.5M | 5.2M | 23.2M | 26.7M | 28.0M | |
Capital Surpluse | 196.4M | 197.1M | 197.3M | 202.1M | 232.4M | 201.3M | |
Net Invested Capital | 2.5M | 5.2M | 23.2M | 23.4M | 20.1M | 13.4M | |
Net Working Capital | 2.0M | 4.8M | 22.8M | 23.0M | 19.6M | 12.9M | |
Capital Stock | 141.0 | 380.0 | 669.0 | 779.0 | 153.0 | 145.35 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for NeuroMetrix Stock analysis
When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.27) | Revenue Per Share 5.664 | Quarterly Revenue Growth (0.29) | Return On Assets (0.19) | Return On Equity (0.30) |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.